Purple Biotech (PPBT) Interest Coverage Ratio Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,150.63% |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | 80.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.76% |
| Dec 31, 2025 | 844.06% |
| Sep 30, 2025 | 6,449.81% |
| Jun 30, 2025 | -142.89% |
| Mar 31, 2025 | -84.71% |
| Dec 31, 2024 | -590.82% |
| Sep 30, 2024 | -98.84% |
| Jun 30, 2024 | 315.27% |
| Mar 31, 2024 | 202.61% |
| Dec 31, 2023 | -99.18% |
| Sep 30, 2023 | 13.11% |
| Jun 30, 2023 | -50.71% |
| Mar 31, 2023 | -51.45% |
| Dec 31, 2022 | 433.95% |
| Sep 30, 2022 | 119.22% |
| Jun 30, 2022 | 98.23% |
| Mar 31, 2022 | -45.24% |
| Dec 31, 2021 | -61.81% |
| Dec 31, 2020 | 265.36% |
| Dec 31, 2019 | 179.14% |
| Dec 31, 2018 | -94.32% |
| Dec 31, 2015 | -982.52% |
| Sep 30, 2015 | -62.68% |